Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.
Current Cancer Therapy Reviews
Title:Chaperone-Hsp90 Conjugation Mediated Targeting Technology for Cancer Treatment: Pioneer Innovation in Nanomedicine
Volume: 20
Author(s): Dilpreet Singh*
Affiliation:
- University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, 140413, India
Export Options
About this article
Cite this article as:
Singh Dilpreet*, Chaperone-Hsp90 Conjugation Mediated Targeting Technology for Cancer Treatment: Pioneer Innovation in Nanomedicine, Current Cancer Therapy Reviews 2024; 20 () . https://dx.doi.org/10.2174/0115733947292956240215105008
DOI https://dx.doi.org/10.2174/0115733947292956240215105008 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers